by Corey Iacono | Dec 22, 2022 | Featured, Thinking Out Loud -Blog
EpiVax 2.0 is coming… EpiVax has developed a science-driven, computationally-enabled, solutions-oriented approach to Vaccines and Biologics over 25 years! . . . Stay tuned for an update on our new mission and vision (EpiVax 2.0) for our 25th Birthday Year in...
by Corey Iacono | Nov 21, 2022 | Featured, Thinking Out Loud -Blog
Dogs Rule! (Cat Lovers Move Over) Seriously, what could be happier than a dog in a bike basket? The owner does all the work while Jack savors the ride! In my next life, I’m coming back as a Dutch dog. Seriously! In Vondelpark (Amsterdam) dogs gambol...
by Admin Epivax | Jan 24, 2022 | Featured, Thinking Out Loud -Blog
Oh-My cron hits Rhode Island I’d like to start by saying Happy New Year! My resolution for 2022 is to hold onto Hope and Joy. To combine both concepts in one eyeful, ->here<- are the three J’s: J-Hope, Jimin, and Jungkook dancing to Megan Thee...
by Annie De Groot | Oct 8, 2021 | Events, Featured
EpiVax had a large contingent at AAPS PharmSci360 in Philadelphia! Check out the EpiVax itinerary below! Always nice to connect with our partners, clients, and friends in Philly. Annie De Groot, MD Speaker Spotlight: Engineering Better Biologics: Does Nature Know...
by Annie De Groot | Jul 8, 2014 | Featured, News
New Immunogenicity Analysis Tool Emerges from Dartmouth-EpiVax-URI Collaboration “In Silico” Host Cell Protein for Protein Therapeutics Providence, RI. Tuesday, July 8th, 2014 A Public-private partnership resulted in the development of a new web-based tool that will...